PTH and chronic kidney disease: However, the unabated development of sHPT in the face of extreme FGF23 elevations poses a dilemma: either the inhibitory action of FGF23 on PTH is not relevant in vivo or the parathyroids may lack responsiveness to FGF23 in CKD.